Icon

SILENOR (nda022036)- (EQ 3MG BASE,EQ 6MG BASE)

DOXEPIN HYDROCHLORIDE CURRAX
EQ 3MG BASE,EQ 6MG BASE
Yes Yes
2030-Sep-07 Expired
None 2013-Mar-17
None No
SILENOR (doxepin) tablets are indicated for the treatment of insomnia characterized by difficulties with sleep maintenance.
5 0 5
Total Other Developers 4
Drugs with Suitability No
EQ 3MG BASE ** ** - - 4
EQ 6MG BASE ** ** - - 4
NDA Sales Available Total Generic Sales Available
Yes 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** ** ****** ***. *********** *** * ********** ** *** ***/*** *, ***** *****, *** **** (**) *****, ****** ****** (***) ***
****** ** ****** ***** ****** *** *********** *** *** *** ********* ** ***** *, *, *-* & *, **********, *** ****** (**) *****-****, ****** ****** (***) ***
****** ** ****** ***** ****** *** *********** *** *** ************ **, **********, *** ****** (**) *****, ****** ****** (***) ***
****** ***** ****** ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ******* ****** ******* ******, *** *********** * *** ***** **, ******** *****, *** **** (**) *****-****, ****** ****** (***) ***
****** *** *** *************** *** *********** **, **** ****, **********, *** ****** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.